Gene: GRIK5
Official Full Name: glutamate ionotropic receptor kainate type subunit 5provided by HGNC
Gene Summary: This gene encodes a protein that belongs to the glutamate-gated ionic channel family. Glutamate functions as the major excitatory neurotransmitter in the central nervous system through activation of ligand-gated ion channels and G protein-coupled membrane receptors. The protein encoded by this gene forms functional heteromeric kainate-preferring ionic channels with the subunits encoded by related gene family members. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37496 | GRIK5 Knockout cell line (A549) | Human | GRIK5 | 1:3~1:4 | Negative | Online Inquiry |
GRIK5 Gene Knockout Cell Lines are genetically engineered cell models in which the GRIK5 gene, which encodes for Glutamate Receptor Ionotropic, Kainate 5, has been deliberately inactivated. This cellular model provides valuable insights into the intricate roles of GRIK5 in neuronal signaling and synaptic plasticity, as well as its implications in various neurological disorders. By employing CRISPR-Cas9 technology, these cell lines serve as indispensable tools for studying the loss-of-function effects associated with GRIK5 and elucidating its contribution to excitatory neurotransmission.
The key biological function of GRIK5 involves modulating synaptic transmission and influencing neuronal excitability. The knockout of this gene disrupts the normal physiological pathways, allowing researchers to investigate alterations in cellular behavior and signaling cascades that lead to improved understanding of conditions like epilepsy, anxiety, and schizophrenia. In research settings, these cell lines facilitate high-throughput screening of compounds aimed at modifying GRIK5-related pathways, fostering drug discovery initiatives.
One of the significant advantages of GRIK5 Gene Knockout Cell Lines over alternatives is the precision and reliability offered by the CRISPR-mediated knockout approach, which ensures a complete and targeted gene inactivation. This specificity minimizes off-target effects that are often associated with other genetic manipulation techniques, leading to more reproducible experimental outcomes. Furthermore, these cell lines are designed for compatibility with various culture systems and experimental assays, enhancing their versatility and application in diverse research domains.
For researchers and clinicians focused on advances in neuropharmacology and the underlying mechanisms of neurodegenerative diseases, GRIK5 Gene Knockout Cell Lines present a compelling value proposition. They not only streamline the experimental process but also empower users to generate robust data that can contribute to therapeutic breakthroughs.
At our company, we pride ourselves on-depth expertise in developing advanced genetic models, and our commitment to quality assures that our GRIK5 Gene Knockout Cell Lines meet the highest standards for research excellence, paving the way for innovative discoveries in neuroscience.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.